§ BIOTECHNOLOGY
USD · BiotechnologyXGN
EXAGEN INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Balyasny Asset Management | 797K | 0.0% | −13% |
| WEXFORD CAPITAL LP | 793K | 0.3% | +70% |
| VANGUARD CAPITAL MANAGEMENT LLC | 679K | 0.0% | n/a |
| VANGUARD CAPITAL MANAGEMENT LLC | 679K | 0.0% | n/a |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 585K | 1.6% | +134% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 538K | 0.0% | −10% |
◇ AC INTELLIGENCE
Top institutional owners for XGN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER55.9% · 0 holders
OTHER33.2% · 39 holders
TACTICAL / MACRO4.5% · 3 holders
SYSTEMATIC / QUANT2.3% · 4 holders
DEALER / BANK1.4% · 11 holders
PASSIVE / INDEX1.3% · 2 holders
DEEP VALUE1.0% · 1 holder
QUALITY / COMPOUNDER0.3% · 1 holder
ACTIVIST0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for XGN in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention XGN yet.